Cookies help us improve your website experience.
By using our website, you agree to our use of cookies.

Latest Post

August 24, 2020

How to Include Elastomers in the Nitrosamine Risk Assessment

Putting together a risk assessment for nitrosamines in your final drug product is an extensive undertaking. Many contributing factors need to be considered, such as the drug substance’s manufacturing process, excipients, buffers, water, production equipment and environment, transportation conditions, packaging, and more. Within this scope, primary packaging components, such as elastomeric closures, also could contribute nitrosamines or precursors.
Bettine Boltres

Dr. Bettine Boltres

Principal Scientific Affairs, Packaging & Delivery Systems

Previous Posts

May 05, 2020

Timelines for Medical Device Regulation and Risk Assessment for Nitrosamines in Europe Extended

Bettine Boltres

Bettine Boltres, PhD.

Principal Scientific Affairs, Packaging & Delivery Systems

Load more